PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: PIPELINE PART 07: MARKET SEGMENTATION BY TYPE Market segmentation by type Comparison by type Pharyngeal cancer - Market size and forecast 2018-2023 Laryngeal cancer - Market size and forecast 2018-2023 Market opportunity by type PART 08: CUSTOMER LANDSCAPE PART 09: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS PART 13: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Bristol-Myers Squibb Co. Eli Lilly and Co. F. Hoffmann-La Roche Ltd. Merck & Co., Inc. Sanofi PART 15: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 16: EXPLORE TECHNAVIO   Exhibit 01: Global oncology therapeutics market Exhibit 02: Segments of global oncology therapeutics market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Global throat cancer therapeutics market pipeline: Overview Exhibit 18: Global throat cancer therapeutics market pipeline: Snapshot Exhibit 19: Type - Market share 2018-2023 (%) Exhibit 20: Comparison by type Exhibit 21: Pharyngeal cancer - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Pharyngeal cancer - Year-over-year growth 2019-2023 (%) Exhibit 23: Laryngeal cancer - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Laryngeal cancer - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by type Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Top 3 countries in North America Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 33: Europe - Year-over-year growth 2019-2023 (%) Exhibit 34: Top 3 countries in Europe Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 36: Asia - Year-over-year growth 2019-2023 (%) Exhibit 37: Top 3 countries in Asia Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 39: ROW - Year-over-year growth 2019-2023 (%) Exhibit 40: Top 3 countries in ROW Exhibit 41: Key leading countries Exhibit 42: Market opportunity Exhibit 43: Impact of drivers and challenges Exhibit 44: Vendor landscape Exhibit 45: Landscape disruption Exhibit 46: Vendors covered Exhibit 47: Vendor classification Exhibit 48: Market positioning of vendors Exhibit 49: Bristol-Myers Squibb Co. - Vendor overview Exhibit 50: Bristol-Myers Squibb Co. - Business segments Exhibit 51: Bristol-Myers Squibb Co. - Organizational developments Exhibit 52: Bristol-Myers Squibb Co. - Geographic focus Exhibit 53: Bristol-Myers Squibb Co. - Key offerings Exhibit 54: Bristol-Myers Squibb Co. - Key customers Exhibit 55: Eli Lilly and Co. - Vendor overview Exhibit 56: Eli Lilly and Co. - Business segments Exhibit 57: Eli Lilly and Co. - Organizational developments Exhibit 58: Eli Lilly and Co. - Geographic focus Exhibit 59: Eli Lilly and Co. - Segment focus Exhibit 60: Eli Lilly and Co. - Key offerings Exhibit 61: Eli Lilly and Co. - Key customers Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 68: F. Hoffmann-La Roche Ltd. - Key customers Exhibit 69: Merck & Co. Inc. - Vendor overview Exhibit 70: Merck & Co. Inc. - Business segments Exhibit 71: Merck & Co. Inc. - Organizational developments Exhibit 72: Merck & Co. Inc. - Geographic focus Exhibit 73: Merck & Co. Inc. - Segment focus Exhibit 74: Merck & Co. Inc. - Key offerings Exhibit 75: Merck & Co. Inc. - Key customers Exhibit 76: Sanofi - Vendor overview Exhibit 77: Sanofi - Business segments Exhibit 78: Sanofi - Organizational developments Exhibit 79: Sanofi - Geographic focus Exhibit 80: Sanofi - Segment focus Exhibit 81: Sanofi - Key offerings Exhibit 82: Sanofi - Key customers Exhibit 83: Validation techniques employed for market sizing Exhibit 84: Definition of market positioning of vendors

Bristol-Myers Squibb Co. Eli Lilly and Co. F. Hoffmann-La Roche Ltd. Merck & Co., Inc. Sanofi